Attenuation of ischemic liver injury by prostaglandin E1 analogue, misoprostol, and prostaglandin I2 analogue, OP-41483

Journal of the American College of Surgeons

Volumn 187, Issue 3, 1998, Pages 276-286

  Totsuka, Eishi ^a,b   Todo, Satoru ^a   Zhu, Yue ^a   Ishizaki, Naoki ^a   Kawashima, Yoshiyuki ^a   Jin, Maeng Bong ^a   Urakami, Atsushi ^a   Shimamura, Tsuyoshi ^a   Starzl, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAPROST; MISOPROSTOL; PROSTACYCLIN; PROSTAGLANDIN E1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DOG; ENZYME RELEASE; FEMALE; HEPATIC ARTERY; HISTOPATHOLOGY; LIVER ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REPERFUSION; SURVIVAL RATE;

ANALYSIS OF VARIANCE; ANIMALS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOPROSTENOL; FEMALE; ISCHEMIA; LIVER; LIVER FUNCTION TESTS; MISOPROSTOL; PLATELET AGGREGATION INHIBITORS; PROSTAGLANDINS, SYNTHETIC; REPERFUSION INJURY;

EID: 0031668962     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(98)00179-3     Document Type: Article

References (57)

1. Stachira J, Tarnawski A, Ivey KJ, et al. Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat. Gastroenterology 1981;81:211-217.
2. 1 on normothermic liver ischemia. Eur Surg Res 1991;23:278-284.
3. Helling TS, Wogahn BM, Olson SA, et al. The effect of prostaglandin E1 on liver adenine nucleotides and cytoplasmic enzymes in porcine model of normothermic hepatic ischemia. Hepatology 1995;22:1554-1559.
4. 2 on ischemia-induced hepatic cell injury. Transplantation 1983;36:238-243.
5. 2 and diltiazem on liver ischemia and reperfusion in pigs. Transplant Proc 1988;20:999-1002.
6. 2 on the tolerance of the rat liver to ischemia. Transplant Proc 1988;20:986.
7. 2 and thromboxane antagonist on liver ischemic injury. Eur Surg Res 1989;21:213-217.
8. 1 reduces injury in hepatic allografts following preservation. J Surg Res 1991;50:595-601.
9. 2 on hepatic mitochondrial function of the preserved rat liver. Tohoku J Exp Med 1986;150:373-379.
10. 1 in an experimental massive hepatic cell necrosis model. Hepatology 1987;7:1184-1188.
11. 2 analogue on superoxide-induced hepatocyte injury. Surgery 1994;116:883-889.
12. 1). Hepatology 1987;7:1104.
13. 1. Transplantation 1989;48:447-453.
14. 1 after clinical liver transplantation. Transplant Proc 1995;27:1862-1867.
15. Cattral MS, Altraif I, Grig PD, et al. Toxic effects of intravenous and oral prostaglandin E therapy in patients with liver disease. Am J Med 1994;97:369-373.
16. 2) in man. Br J Clin Pharmacol 1982;14:177-185.
17. 1 in man. J Clin Invest 1975;56:1404-1410.
18. 2) in aqueous solutions. Prostaglandins 1978;15:943-954.
19. 1 in liver transplantation. Hepatology 1995;21:366-372.
20. Ismail T, Ayres R, Kiff P, et al. Enisoprost in liver transplantation. Transplantation 1995;59:1298-1301.
21. Manasia AR, Leibowitz AB, Miller CM, et al. Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients. J Am Coll Surg 1996;182:347-352.
22. Bauer RF. Misoprostol preclinical pharmacology. Dig Dis Sci 1985;30:118S-125S.
23. Foote EF, Lee DR, Karim A, et al. Disposition of misoprostol and its active metabolite in patients with normal and impaired renal function. J Clin Pharmacol 1995;35:384-389.
24. Yui Y, Takatsu Y, Hattori R, et al. A new stable analogue (15-cyclopentyl-omega-pentanor-5(E)-carbacyclin). Jpn Circ J 1985; 49:571-575.
25. Todo S, Zhu Y, Zhang S, et al. Attenuation of ischemic liver injury by augmentation of endogenous adenosine. Transplantation 1997;63:217-223.
26. Urakami A, Todo S, Zhu Y, et al. Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody, AwETN40. J Am Coll Surg 1997;185:358-364.
27. Mashige F, Imai K, Osuga T A simple and sensitive assay of total serum bile acids. Clinica Chimica Acta 1976;70:79-86.
28. Hamamoto I, Takay S, Todo S, et al. Can adenine nucleotides predict primary nonfunction of the human liver homograft? Transplant Int 1994;7:89-95.
29. Atkinson DE. The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 1968;7:4030-4034.
30. Stevens A. Enzyme histochemistry: Diagnostic applications. In: Bancroft JD, and Stevens A, eds. Theory and practice of histological techniques. New York: Churchill Livingstone; 1996:401-411.
31. 1. Biochem Biophys Res Commun 1973;55:522-529.
32. Wise H, Jones RL. Characterization of prostanoid receptors on rat neutrophils. Br J Pharmacol 1994;113:581-587.
33. Levine RA. The role of cyclic AMP in hepatic and gastrointestinal function. Gastroenterology 1970;59:280-300.
34. Marubayashi S, Takenaka M, Dohi K, et al. Adenine nucleotide metabolism during hepatic ischemia and subsequent blood reflow periods and its relation to organ viability. Transplantation 1980;30:294-296.
35. Harvey PRC, Iu S, McKeown CMB, et al. Adenine nucleotide tissue concentrations and liver allograft viability after cold preservation and warm ischemia. Transplantation 1988;45:1016-1020.
36. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;17:159-163.
37. 2+ uptake in isolated hepatic plasma membrane vesicles. Ann N Y Acad Sci 1982;402:440-442.
38. 2+ and the stimulation of a nonlysosomal proteolytic system. J Biol Chem 1986;261:14628-14635.
39. Lim SP, Andrews FJ, Christophi C, O'Brien PE. Microvascular changes in liver after ischemia-reperfusion injury. Protection with misoprostol. Dig Dis Sci 1994;39:1683-1690.
40. Quiroga J, Prieto J. Liver cytoprotection by prostaglandins. Pharmacol Ther 1993;58:67-92.
41. + channel by cyclic AMP in cultured porcine coronary artery smooth muscle cells. Life Sci 1993;53: 1129-1135.
42. 2 mimic (U46619). Can J Physiol Pharmacol 1991;69:599-604.
43. Geiger J, Nolte C, Walter U. Regulation of calcium mobilization and entry in human platelets by endothelium-derived factors. Am J Physiol 1994;267:C236-C244.
44. Colletti LM, Remick DG, Burtch GD, et al. Role of tumor necrosis factor-a in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85: 1936-1943.
45. Suzuki S, Toledo-Pereyra LH, Rodriguez F, Lopez F. Role of Kupffer cells in neutrophil activation and infiltration following total hepatic ischemia and reperfusion. Cire Shock 1994;42:204-209.
46. Welbourn CRB, Goldman G, Paterson IS, et al. Pathophysiology of ischemia reperfusion injury: central role of the neutrophil. Br J Surg 1991;78:651-655.
47. Russell RC, Roth AC, Kucan JO, Zook EG. Reperfusion injury and oxygen free radicals: a review. J Reconst Microsurg 1989;5: 79-84.
48. Mitsuyama T, Takeshige K, Minakami S. Cyclic AMP inhibits the respiratory burst of electropermeabilized human neutrophils at a downstream site of protein kinase C. Biochemica Biophysica Acta 1993;1177:167-173.
49. 2 and dexamethasone. J Hepatol 1988;7:352-361.
50. Visser JJ, Noorloos AAB, Meijer S, Hoitsma HFW. Serum total bile acids monitoring after experimental orthotopic liver transplantation. J Surg Res 1984;36:147-153.
51. Lim SP, Andrews FJ, Christophi C, O'Brien PE. Misoprostol hepatoprotection against ischemia-reperfusion-induced liver injury in the rat. Dig Dis Sci 1992;37:1275-1281.
52. Kalra PA, Litherland D, Sallomi DF, et al. Cardiac standstill induced by prostaglandin pessaries. Lancet 1989;24:1460-1461.
53. 2. Am J Obstet Gynecol 1991; 165:359-360.
54. 2 in anaesthetized dogs. Br J Pharmacol 1980; 68:437-447.
55. Hintze TH. Reflex regulation of the circulation after stimulation of cardiac receptors by prostaglandins. Federation Proc 1987; 46: 73-80.
56. Todo S, Yokoi H, Podesta L, et al. Amelioration of normothermic canine liver ischemia with prostacyclin. Transplant Proc 1988; 20:965-968.
57. 2) in the dog. Br J Pharmacol 1978;64:315-320.